MISSION Therapeutics Receives £20m Series B Funding

News   Dec 09, 2013

 
MISSION Therapeutics Receives £20m Series B Funding
 
 
 

RELATED ARTICLES

Pfizer to Organize for Future Growth

News

Pfizer Inc. announced it will organize the company into three businesses.

READ MORE

Availability of Brain Tumor Surgery Dye Increases for NHS Patients

News

A chemical dye that lights up brain tumours during surgery should be available to more NHS patients in England, according to the National Institute for Health and Care and Excellence (NICE).

READ MORE

How Well Do Cancer Drugs Hit Their Targets? Here’s How to Find Out

News

Scientists have developed a technique that allows them to measure how well cancer drugs reach their targets inside the body. It shows individual cancer cells in a tumor in real time, revealing which cells interact with the drug and which cells the drug fails to reach.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy